医学
优势比
溶栓
改良兰金量表
置信区间
冲程(发动机)
内科学
逻辑回归
随机化
临床终点
随机对照试验
物理疗法
心肌梗塞
缺血性中风
缺血
工程类
机械工程
作者
Xinwen Ren,Yang William Zhao,Menglu Ouyang,Qiang Li,Chen Chen,Shoujiang You,Thompson Gordon Robinson,Richard I. Lindley,Hisatomi Arima,Xiaoying Chen,John Philip Chalmers,Craig S. Anderson,Lili Song,Xia Wang,The ENCHANTED Investigators
摘要
INTRODUCTION: The influence of multiple long-term conditions on the outcomes from acute ischaemic stroke (AIS) is not well defined. This study aimed to determine the association of multiple long-term conditions in participants of the Enhanced Control of Hypertension and Thrombolysis Stroke Study (ENCHANTED). METHODS: ENCHANTED was an international, multicentre, 2 × 2 quasi-factorial, open, randomized controlled, blinded endpoint assessed trial that assessed the effectiveness and safety of intensive blood pressure lowering and low-dose thrombolysis against standard of care in adults with AIS. Multiple long-term condition was defined as two or more coexisting chronic conditions according to medical history. The primary outcome was function recovery (distribution of scores on the modified Rankin scale) and mortality at 90 days post-randomization. Associations were estimated in multivariate logistic regression models, and an assessment of heterogeneity was undertaken in subgroups including age, sex, baseline systolic blood pressure, and clinical features. RESULTS: In 4,566 AIS participants (mean age 66.7 years, 37.8% female), those with multiple long-term conditions were older, more often female, and had more severe neurological impairment. Multiple long-term conditions increased the odds of poor functional outcome (adjusted odds ratio [aOR] 1.16, 95% confidence interval [CI]: 1.03-1.30; p = 0.020) and mortality (aOR 1.35, 95% CI: 1.04-1.76; p = 0.024). The association between multiple long-term conditions and mortality/functional outcome was consistent across all subgroups. CONCLUSION: Individuals with multiple long-term conditions have higher odds of poor functional outcome and death after thrombolytic treatment for AIS.
科研通智能强力驱动
Strongly Powered by AbleSci AI